Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 1, 2009, Pages 36-42

  Rheinlaender, C ^a   Helfenstein, D ^a   Walch, E ^a   Berns, M ^a   Obladen, M ^a   Koehne, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bilirubin; Ibuprofen; Indomethacin; Outcome; PDA

Indexed keywords

BILIRUBIN; IBUPROFEN; INDOMETACIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PHOTOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT; VERY LOW BIRTH WEIGHT;

BILIRUBIN; CHILD, PRESCHOOL; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; FEMALE; HEMODYNAMICS; HUMANS; HYPERBILIRUBINEMIA; IBUPROFEN; INDOMETHACIN; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; RETROSPECTIVE STUDIES;

EID: 57449112516     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2008.01007.x     Document Type: Article

References (24)

1. Oh W, Tyson JE, Fanaroff AA, Vohr BR, Perritt R, Stoll BJ, et al. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics 2003 112 : 773 9.
2. Sampath V, Bowen J, Gibson F. Risk factors for adverse neurodevelopment in extremely low birth weight infants with normal neonatal cranial ultrasound. J Perinatol 2005 25 : 210 5.
3. Ahlfors CE. Effect of ibuprofen on bilirubin-albumin binding. J Pediatr 2004 144 : 386 8.
4. Cooper-Peel C, Brodersen R, Robertson A. Does ibuprofen affect bilirubin-albumin binding in newborn infant serum? Pharmacol Toxicol 1996 79 : 297 9.
5. Aranda JV, Thomas R. Systematic review: intravenous Ibuprofen in preterm newborns. Semin Perinatol 2006 30 : 114 20.
6. Desfrere L, Mourdie J, Barbier A, Moriette G. Effect of Ibuprofen on unbound bilirubin levels in preterm infants. E-PAS 2007 61 : 8447.11.
7. Aranda JV, Varvarigou A, Beharry K, Bansal R, Bardin C, Modanlou, et al. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr 1997 86 : 289 93.
8. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 2002 161 : 202 7.
9. Van Overmeire B, Touw D, Schepens PJ, Kearns GL, Van Den Anker JN. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther 2001 70 : 336 43.
10. Maisels MJ, Watchko JF. Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2003 88 : F459 63.
11. Brandt. Griffith Entwicklungsskalen (GES) zur Beurteilung der Entwicklung in den ersten beiden Lebensjahren. Weinheim und Basel : Beltz-Verlag, 1983.
12. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005 116 : 1353 60.
13. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001 163 : 1723 9.
14. An international classification of retinopathy of prematurity. II. The classification of retinal detachment. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. Arch Ophthalmol 1987 105 : 906 12.
15. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978 92 : 529 34.
16. Resch B, Vollaard E, Maurer U, Haas J, Rosegger H, Muller W. Risk factors and determinants of neurodevelopmental outcome in cystic periventricular leucomalacia. Eur J Pediatr 2000 159 : 663 70.
17. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev Med Child Neurol 2000 42 : 816 24.
18. Ahlfors CE. Unbound bilirubin associated with kernicterus: a historical approach. J Pediatr 2000 137 : 540 4.
19. Desfrere L. Effect of intravenous Ibuprofen on bilirubin binding in preterm infants: interim data. Eur J Pediatr 2006 165 (Suppl 1 385.
20. Van Overmeire B. Ibuprofen, bilirubin and albumin: the importance of a balance. Eur J Pediatr 2006 165 (Suppl 1 113 114.
21. Mills JF, Tudehope D. Fibreoptic phototherapy for neonatal jaundice. Cochrane Database Syst Rev 2001 CD002060.
22. Beail N. A comparative study of profoundly multiply handicapped children's scores on the Bayley and the Griffiths developmental scales. Child Care Health Dev 1985 11 : 31 6.
23. Watchko JF. Hyperbilirubinemia and bilirubin toxicity in the late preterm infant. Clin Perinatol 2006 33 : 839 52.
24. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2005 CD003481.